Page last updated: 2024-12-05

diallyl disulfide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Diallyl disulfide (DADS) is a sulfur-containing compound naturally found in garlic. It is synthesized by the reaction of allyl chloride with sodium sulfide. DADS possesses various biological activities, including antioxidant, antimicrobial, and anti-inflammatory properties. Research on DADS focuses on its potential health benefits, such as its ability to reduce cardiovascular disease risk, protect against cancer, and improve immune function. Its potent antimicrobial activity against bacteria, fungi, and parasites has also garnered significant attention. DADS is studied extensively due to its therapeutic potential and its role in the characteristic flavor and odor of garlic.'

diallyl disulfide: major constituent of garlic oil [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

diallyl disulfide : An organic disulfide where the organic group specified is allyl. It has been isolated from garlic and other species of the genus Allium. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID16590
CHEMBL ID366603
CHEBI ID4488
SCHEMBL ID93944
MeSH IDM0090577

Synonyms (79)

Synonym
2-propenyl disulfide
allyl disulphide
hsdb 595
einecs 218-548-6
di(2-propenyl) disulfide
fema no. 2028
brn 1699241
ai3-35128
ccris 6290
nsc 29228
AKOS015840490
disulfide, di-2-propenyl
nsc29228
nsc-29228
diallyl disulphide
allyl disulfide
NCI60_002410
3-(allyldisulfanyl)-1-propene
3,3'-dithiobis(prop-1-ene)
3-(prop-2-en-1-yldisulfanyl)prop-1-ene
3,3'-disulfanediylbis(prop-1-ene)
4,5-dithia-1,7-octadiene
CHEBI:4488 ,
2-propenyl disulphide
3-(allyldisulfanyl)prop-1-ene
dialls2
2179-57-9
C08369
diallyl disulfide
allyl disulfide, >=80%, fg
allyl disulfide, technical grade, 80%
NCGC00095294-02
NCGC00095294-01
SPECTRUM1505174
D0071
3-(prop-2-enyldisulfanyl)prop-1-ene
diallyldisulfide
CHEMBL366603 ,
3-allyldisulfanyl-propene
bdbm50318453
5hi47o6oa7 ,
unii-5hi47o6oa7
disulfide, di-2-propen-1-yl
tox21_302178
dtxcid7015206
dtxsid9035206 ,
cas-2179-57-9
NCGC00255533-01
3-(prop-2-enyldisulfanyl)-1-propene
A815665
FT-0624594
diallyl disulfide [hsdb]
allyl disulfide [usp-rs]
allyl disulfide [fhfi]
CCG-214421
1,2-diallyldisulfane
SCHEMBL93944
diallyldisulphide
di-propenyl disulfide
di-2-propenyl disulfide
3-(allyldisulfanyl)-1-propene #
diallyl disulfide, analytical standard
mfcd00008656
di-2-propenyl disulfide, 9ci
allyl disulfide, united states pharmacopeia (usp) reference standard
SR-05000002379-1
sr-05000002379
diallyl disulfide, >=98% (hplc)
fema 2028
garlicin?
J-014293
di-allyl-disulfide
Q419633
EN300-691227
di-2-propenyldisulfide
D89587
nsc-797351
nsc797351
HY-W015635

Research Excerpts

Overview

Diallyl disulfide (DADS) is an allicin extract, with detoxifying, antibacterial, and cardiovascular disease protective effects. It is a major organosulfur compound found in garlic oil that is widely used as a flavoring agent.

ExcerptReferenceRelevance
"Diallyl disulfide is a redox-sensitive molecule involved in redox cell activities, and thymine is a uracil derivative and one of the well-known bioactive compounds that can enhance the pharmacological activity of doxorubicin."( Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells.
Amerhanova, SK; Antipin, IS; Bakhtiozina, LR; Kadirov, MK; Lyubina, AP; Mansurova, EE; Nizameev, IR; Semenov, VE; Shulaeva, MM; Voloshina, AD; Ziganshina, AY, 2023
)
1.63
"Diallyl disulfide (DADS) is an allicin extract, with detoxifying, antibacterial, and cardiovascular disease protective effects."( Diallyl disulfide attenuates pyroptosis via NLRP3/Caspase-1/IL-1β signaling pathway to exert a protective effect on hypoxic-ischemic brain damage in neonatal rats.
Chen, B; Fang, Y; Feng, X; Lin, Z; Pang, M; Wang, H; Wu, Y; Zheng, Y; Zhu, J; Zhu, T, 2023
)
3.07
"Diallyl disulfide (DADS) is an organosulfur compound derived mainly from garlic and genus Allium plants, which possess diverse biological properties. "( Antiarthritic Activity of Diallyl Disulfide against Freund's Adjuvant-Induced Arthritic Rat Model.
Chen, Y; Jin, X; Tan, X; Xue, R, 2018
)
2.22
"Diallyl disulfide (DADS) is a garlic-derived organosulfur compound. "( The activation of HO-1/Nrf-2 contributes to the protective effects of diallyl disulfide (DADS) against ethanol-induced oxidative stress.
Song, FY; Xie, KQ; Yu, LH; Zeng, T; Zhang, CL; Zhao, XL; Zhu, ZP, 2013
)
2.07
"Diallyl disulfide (DADS) is a major organosulfur compound found in garlic oil that is widely used as a flavoring agent. "( Diallyl-disulfide, an organosulfur compound of garlic, attenuates airway inflammation via activation of the Nrf-2/HO-1 pathway and NF-kappaB suppression.
Ahn, KS; Hong, J; Jeon, CM; Kim, HS; Kim, JC; Kwon, OK; Oh, SR; Shin, IS; Shin, NR, 2013
)
1.83
"Diallyl disulfide (DADS) is a natural organosulfur compound isolated from garlic. "( DADS suppresses human esophageal xenograft tumors through RAF/MEK/ERK and mitochondria-dependent pathways.
Cai, C; Feng, C; Jing, F; Li, X; Liang, R; Liu, D; Liu, X; Ma, H; Wang, J; Wang, X; Xue, X; Yin, X; Zhang, J; Zhuang, K, 2014
)
1.85
"Diallyl disulfide (DADS) is a natural organosulfur compound, isolated from garlic."( Diallyl disulfide induces G2/M arrest and promotes apoptosis through the p53/p21 and MEK-ERK pathways in human esophageal squamous cell carcinoma.
Feng, C; Li, Z; Liu, D; Liu, X; Ma, H; Wang, X; Xu, K; Yin, X; Zhang, J; Zhang, R; Zhang, S, 2014
)
2.57
"Diallyl disulfide (DADS) is a primary component of garlic, which has chemopreventive potential. "( Identification of potential targets for differentiation in human leukemia cells induced by diallyl disulfide.
Ai, X; He, J; Hu, H; Ji, X; Jiang, H; Ling, H; Liu, F; Su, Q; Tan, H; Wu, Y; Yi, L; Zeng, X, 2017
)
2.12
"Diallyl disulfide (DADS) is a garlic-derived natural organosulfur compound."( Diallyl Disulfide Suppresses the Inflammation and Apoptosis Resistance Induced by DCA Through ROS and the NF-κB Signaling Pathway in Human Barrett's Epithelial Cells.
Di, J; Feng, C; Liu, D; Luo, Y; Nian, Y; Wu, J; Yin, X; Zhang, J; Zhang, R, 2017
)
2.62
"Diallyl disulfide (DADS) is a degradation product of allicin which is contained in garlic. "( Protective effects of diallyl disulfide against acetaminophen-induced nephrotoxicity: A possible role of CYP2E1 and NF-κB.
Kim, JC; Kim, JW; Kim, SH; Ko, JW; Lee, IC; Moon, C; Park, SH; Shin, IS; Shin, JY; Shin, NR, 2017
)
2.21
"Diallyl disulfide (DADS) is a major component of an oil-soluble allyl sulfide garlic (Allium sativum) derivative, which has been shown to exert a potential for anti-cancer activity. "( Anti-invasive activity of diallyl disulfide through tightening of tight junctions and inhibition of matrix metalloproteinase activities in LNCaP prostate cancer cells.
Choi, YH; Choi, YW; Kang, HS; Kim, GY; Kim, JI; Kwon, TK; Lee, SJ; Shin, DY; Yoo, YH; Yoon, MK, 2010
)
2.1
"Diallyl disulfide (DADS) is a major organo-sulfur compound derived from garlic (Allium sativum), which inhibits the proliferation of various types of cancer cells. "( Diallyl disulfide induces caspase-dependent apoptosis via mitochondria-mediated intrinsic pathway in B16F-10 melanoma cells by up-regulating p53, caspase-3 and down-regulating pro-inflammatory cytokines and nuclear factor-κβ-mediated Bcl-2 activation.
Kutan, G; Pratheeshkumar, P; Thejass, P, 2010
)
3.25
"Diallyl disulfide (DADS) is a chemopreventive agent that can induce apoptosis in many tumor cells. "( Diallyl disulfide induces apoptosis in human leukemia HL-60 cells through activation of JNK mediated by reactive oxygen.
Ji, XX; Lin, M; Ma, YH; Su, Q; Tan, H; Tang, Y; Wen, L; Yi, L, 2010
)
3.25
"Diallyl disulfide (DADS) is a major sulfur compound of garlic, and exerts anti-inflammatory, immune-modulatory, and enhancing sympathetic activity effects. "( Diallyl disulfide reduced dose-dependently the number of lymphocyte subsets and monocytes in rats.
Abe, I; Hashizume, Y; Imaizumi, K; Kobayashi, A; Mitsuhashi, R; Sato, S; Shiono, C; Shirato, K; Tachiyashiki, K, 2012
)
3.26
"Diallyl disulfide (DADS) is a naturally occurring organosulfur compound, from garlic, which exerts pleiotropic biological effects. "( Diallyl disulfide (DADS) increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines.
Chaumontet, C; Cherbuy, C; Druesne, N; Duée, PH; Martel, P; Mayeur, C; Pagniez, A; Thomas, M, 2004
)
3.21
"Diallyl disulfide (DADS) is a sulfur compound derived from garlic. "( Repetitive treatments of colon HT-29 cells with diallyl disulfide induce a prolonged hyperacetylation of histone H3 K14.
Chaumontet, C; Cherbuy, C; Druesne, N; Duée, PH; Martel, P; Mayeur, C; Pagniez, A; Thomas, M, 2004
)
2.02
"Diallyl disulfide (DADS) is a naturally occurring organosulfur compound, from garlic (Allium sativum), which exerts anti-neoplasm activity."( Diallyl disulfide inhibits N-acetyltransferase activity and gene expression in human esophagus epidermoid carcinoma CE 81T/VGH cells.
Chen, SC; Chung, JG; Lai, WW; Lin, JP; Yu, CS; Yu, FS, 2005
)
2.49
"Diallyl disulfide (DADS) is a major constituent of garlic. "( Erk is involved in the differentiation induced by diallyl disulfide in the human gastric cancer cell line MGC803.
He, J; Ling, H; Luo, ZY; Song, Y; Su, Q; Tan, H; Yuan, JP; Zeng, X; Zhang, LY; Zhou, XT, 2006
)
2.03
"Diallyl disulfide (DADS) is an organosulfur compound from garlic, which inhibits colon tumor cell proliferation. "( Diallyl disulfide increases CDKN1A promoter-associated histone acetylation in human colon tumor cell lines.
Chaumontet, C; Cherbuy, C; Druesne-Pecollo, N; Duée, PH; Martel, P; Pagniez, A; Thomas, M, 2006
)
3.22
"Diallyl disulfide (DADS) is an organosulfur compound from garlic which exhibits various anticarcinogenic properties including inhibition of tumor cell proliferation. "( In vivo treatment by diallyl disulfide increases histone acetylation in rat colonocytes.
Bruneau, A; Chaumontet, C; Cherbuy, C; Druesne-Pecollo, N; Duée, PH; Martel, P; Pagniez, A; Thomas, M; Vaugelade, P, 2007
)
2.1
"Diallyl disulfide (DADS) is an oil-soluble organosulfur compound found in garlic. "( Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines.
Hioki, K; Kiuchi, K; Nakagawa, H; Senzaki, H; Tanaka, K; Tsubura, A; Tsuta, K, 2001
)
2.04
"Diallyl disulfide (DADS) is a constituent of garlic that suppresses neoplastic cell growth and induces apoptosis."( Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells.
Baek, SJ; Bottone, FG; Eling, TE; Nixon, JB, 2002
)
2.48

Effects

Diallyl disulfide (DADS) has been shown to cause G2/M phase cell cycle arrest in several human cancers. The underlying mechanisms remain largely unknown.

ExcerptReferenceRelevance
"Diallyl disulfide (DADS) has been suggested to possess hepatoprotection against alcoholic liver disease (ALD) by a couple of pilot studies, while the underlying mechanisms remain largely unknown. "( Diallyl disulfide ameliorates ethanol-induced liver steatosis and inflammation by maintaining the fatty acid catabolism and regulating the gut-liver axis.
Guo, FF; Liu, H; Liu, SX; Wang, S; Zeng, T; Zhang, CL, 2022
)
3.61
"Diallyl disulfide (DADS) has been shown to cause G2/M phase cell cycle arrest in several human cancers. "( Chk1, but not Chk2, is responsible for G2/M phase arrest induced by diallyl disulfide in human gastric cancer BGC823 cells.
Ai, XH; Bo, S; Dai, WX; Hao, J; Hong, X; Hui, H; Hui, L; Li, W; Lin, D; Qi, S; Wu, YH, 2014
)
2.08
"Diallyl disulfide (DADS) has been shown to have multi-targeted antitumor activities. "( Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.
Ai, XH; Jiang, H; Ling, H; Liu, F; Ma, YH; Su, B; Su, J; Su, Q; Wu, YH; Xia, H; Yang, BM; Zeng, X; Zeng, Y; Zhang, S; Zhou, ZG, 2016
)
3.32
"Diallyl disulfide (DADS) has been demonstrated to exert potent anticancer effects in vitro and in vivo. "( Subcellular localization of DJ-1 in human HL-60 leukemia cells in response to diallyl disulfide treatment.
He, J; Li, Q; Qin, J; Su, Q; Tan, H; Tang, Y; Wang, J; Yang, Y; Yi, L, 2016
)
2.11
"Diallyl disulfide (DADS) has shown potential as a therapeutic agent in various cancers. "( Involvement of Mcl1 in diallyl disulfide-induced G2/M cell cycle arrest in HL-60 cells.
Feng, MY; Ji, XX; Su, Q; Tan, H; Tang, Y; Wen, L; Yi, L, 2012
)
2.13

Actions

Diallyl disulfide (DADS) can inhibit the proliferation of various cancer cell lines in vitro, but little is known about its in vivo antitumor effect.

ExcerptReferenceRelevance
"Diallyl disulfide (DADS) can inhibit growth of various cancer cell lines in vitro, but little is known about its in vivo antitumor effect. "( [Antitumor effect of diallyl disulfide on human gastric cancer MGC803 cells xenograft in nude mice].
Dong, L; Liao, QJ; Ling, H; Su, Q; Xiang, SL; Xiao, XL; Zhou, XT, 2005
)
2.09
"Diallyl disulfide (DADS) can inhibit the proliferation of various cancer cell lines in vitro, but little is known about its in vivo antitumor effect. "( [Inhibitory effect of diallyl disulfide on proliferation of human colon cancer cell line SW480 in nude mice].
Liao, QJ; Song, Y; Su, J; Su, Q; Tang, HL; Zhou, XT, 2007
)
2.1

Treatment

ExcerptReferenceRelevance
"Treatment with diallyl disulfide, a constituent of garlic oil, irreversibly inactivated microsomal and a soluble 50 kDa form of HMG-CoA reductase. "( On the involvement of intramolecular protein disulfide in the irreversible inactivation of 3-hydroxy-3-methylglutaryl-CoA reductase by diallyl disulfide.
Banerji, A; Kadam, SM; Omkumar, RV; Ramasarma, T, 1993
)
0.84

Compound-Compound Interactions

ExcerptReferenceRelevance
" Meanwhile, the effects described above were enhanced when garlicin was combined with erythromycin."( [Mechanism reversing MDR of K562/A02 by garlicin combined with erythromycin].
Chen, W; Liu, X; Wang, H; Xu, B; Yu, M, 2008
)
0.35

Bioavailability

ExcerptReferenceRelevance
" The bioavailability of allyl thiosulfinates from these tablets, measured as breath allyl methyl sulfide, was found to be complete and equivalent to that of crushed fresh garlic."( Composition, stability, and bioavailability of garlic products used in a clinical trial.
Gardner, CD; Lawson, LD, 2005
)
0.33
" Garlic supplements differ in bioavailability of key phytochemicals."( Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial.
Balise, RR; Block, E; Chatterjee, LM; Gardner, CD; Kiazand, A; Kraemer, HC; Lawson, LD, 2007
)
0.34
" This increase in nitric oxide bioavailability by the allyl sulfides was attenuated by wortmannin."( Diallyl disulfide and diallyl trisulfide protect endothelial nitric oxide synthase against damage by oxidized low-density lipoprotein.
Chen, HW; Lei, YP; Lii, CK; Liu, CT; Sheen, LY, 2010
)
1.8
" We have prepared solid lipid nanoparticle formulation of cytotoxic agent di-allyl-disulfide (DADS) to overcome its bioavailability issues."( RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies.
Chintamaneni, PK; Nandha Kumar, S; Pindiprolu, SKSS; Siddhartha, VT; Tummala, S, 2018
)
0.72

Dosage Studied

ExcerptRelevanceReference
" Dipropenyl disulfide was much less active, while little effect on enzyme activity was seen in animals dosed with dipropyl disulfide."( Relative activities of organosulfur compounds derived from onions and garlic in increasing tissue activities of quinone reductase and glutathione transferase in rat tissues.
Munday, CM; Munday, R, 2001
)
0.31
"Prophylactic dosage of antifungal agents (garlicin or low dosage fluconazole) can reduce the incidence of fungal infection in patients with SAP."( Prevention and therapy of fungal infection in severe acute pancreatitis: A prospective clinical study.
Ai, ZL; Chen, JW; He, YM; Jiang, CQ; Lei, DX; Liu, ZS; Lv, XS; Qian, Q; Sun, Q; Yuan, YF, 2003
)
0.32
" Dosing with 200 mg/kg of each of the OSCs used in this study increased hepatic CYP3A2 protein levels at all time points."( Modulation of cytochrome P450 enzymes by organosulfur compounds from garlic.
Davenport, DM; Wargovich, MJ, 2005
)
0.33
" In a mouse xenograft model of neovasculogenesis, DATS consumption induced the formation of new blood vessels at a dosage of 10 mg/kg of body weight/day."( Organosulfur garlic compounds induce neovasculogenesis in human endothelial progenitor cells through a modulation of MicroRNA 221 and the PI3-K/Akt signaling pathways.
Chiang, EP; Chiu, SC; Kuo, YH; Pai, MH; Tang, FY; Wang, FY; Wang, YC, 2013
)
0.39
" Those products include intramammary, topical and intravaginal preparations, each dosed at two levels."( Pharmacokinetic analysis of thymol, carvacrol and diallyl disulfide after intramammary and topical applications in healthy organic dairy cattle.
Anderson, KL; Baynes, RE; Mason, SE; Mullen, KAE; Washburn, SP; Yeatts, JL, 2017
)
0.71
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
antifungal agentAn antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organic disulfideCompounds of structure RSSR in which R and R' are organic groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (28)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency12.58930.003245.467312,589.2998AID2517
15-lipoxygenase, partialHomo sapiens (human)Potency25.11890.012610.691788.5700AID887
AR proteinHomo sapiens (human)Potency61.53610.000221.22318,912.5098AID1259243; AID1259247
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency6.30960.011212.4002100.0000AID1030
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency13.68540.001723.839378.1014AID743083
Histone H2A.xCricetulus griseus (Chinese hamster)Potency40.09540.039147.5451146.8240AID1224845
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency8.91250.001815.663839.8107AID894
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency19.95260.354828.065989.1251AID504847
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency25.11890.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Cellular tumor antigen p53Homo sapiens (human)Potency75.51010.002319.595674.0614AID651631; AID720552
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Fatty acid synthaseGallus gallus (chicken)IC50 (µMol)145.00006.15007.63008.3700AID1802931
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)66.27500.00033.166210.0000AID482138; AID482142
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (144)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
lactate metabolic processFatty acid synthaseGallus gallus (chicken)
fatty acid biosynthetic processFatty acid synthaseGallus gallus (chicken)
positive regulation of appetiteFatty acid synthaseGallus gallus (chicken)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (52)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
single-stranded DNA bindingFatty acid synthaseGallus gallus (chicken)
fatty acid synthase activityFatty acid synthaseGallus gallus (chicken)
[acyl-carrier-protein] S-acetyltransferase activityFatty acid synthaseGallus gallus (chicken)
[acyl-carrier-protein] S-malonyltransferase activityFatty acid synthaseGallus gallus (chicken)
3-oxoacyl-[acyl-carrier-protein] synthase activityFatty acid synthaseGallus gallus (chicken)
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activityFatty acid synthaseGallus gallus (chicken)
(3R)-3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseGallus gallus (chicken)
(3R)-3-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseGallus gallus (chicken)
(3R)-3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseGallus gallus (chicken)
fatty acyl-[ACP] hydrolase activityFatty acid synthaseGallus gallus (chicken)
phosphopantetheine bindingFatty acid synthaseGallus gallus (chicken)
(3R)-3-hydroxybutanoyl-[acyl-carrier-protein] hydratase activityFatty acid synthaseGallus gallus (chicken)
(3R)-3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseGallus gallus (chicken)
enoyl-[acyl-carrier-protein] reductase (NADPH) activityFatty acid synthaseGallus gallus (chicken)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (21)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
cytoplasmFatty acid synthaseGallus gallus (chicken)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (35)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID717930Cytotoxicity against MDCK cells assessed as decrease in cell viability after 16 hrs by tetrazolium salt WST-1 assay2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Effect of allyl sulfides from garlic essential oil on intracellular ca2+ levels in renal tubular cells.
AID1622990Antiproliferative activity against human A549 cells2018European journal of medicinal chemistry, Oct-05, Volume: 158HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors.
AID1637828Cytotoxicity against human A549 cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo luminescent assay2019MedChemComm, Jan-01, Volume: 10, Issue:1
Synthesis and preliminary evaluation of the anti-cancer activity on A549 lung cancer cells of a series of unsaturated disulfides.
AID777385Induction of H2S release in PBS buffer 10x at pH 7.4 assessed as maximal concentration of H2S at steady state after 15 mins2013ACS medicinal chemistry letters, Oct-10, Volume: 4, Issue:10
Arylthioamides as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo.
AID1778701Drug metabolism in human BSMC cells assessed as intracellular H2S release by measuring increase in fluorescence index at 100 uM measured every 5 mins for 60 mins by WSP-1 dye based spectrofluorometric analysis2021European journal of medicinal chemistry, Oct-05, Volume: 221Hybrids between H
AID717931Cell cycle arrest in MDCK cells assessed as accumulation at G1 phase at 100 uM after 16 hrs by flow cytometric analysis (Rvb = 55.7%)2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Effect of allyl sulfides from garlic essential oil on intracellular ca2+ levels in renal tubular cells.
AID1622991Antiproliferative activity against human SK-MEL-2 cells2018European journal of medicinal chemistry, Oct-05, Volume: 158HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors.
AID482142Activation of TRPA1 channel2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID482138Agonist activity at human TRPA1 channel expressed in CHO cells assessed as increase in intracellular calcium levels2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID717932Cell cycle arrest in MDCK cells assessed as accumulation at S phase at 100 uM after 16 hrs by flow cytometric analysis (Rvb = 24.5%)2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Effect of allyl sulfides from garlic essential oil on intracellular ca2+ levels in renal tubular cells.
AID670330Inhibition of human ENaC alpha-beta-gamma expressed in Xenopus laevis oocytes assessed as effect on transmembrane currents at 1 mM by two-electrode voltage-clamp technique2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
Thiol-reactive compounds from garlic inhibit the epithelial sodium channel (ENaC).
AID644231Cytotoxicity against human HCT116 cells expressing p53 assessed as reduction in cell viability at 50 uM from 24 to 48 hrs by MTT assay2012Bioorganic & medicinal chemistry, Feb-15, Volume: 20, Issue:4
Coumarin polysulfides inhibit cell growth and induce apoptosis in HCT116 colon cancer cells.
AID1622988Antiproliferative activity against human HCT15 cells2018European journal of medicinal chemistry, Oct-05, Volume: 158HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors.
AID1475786Drug metabolism in HSMC assessed as H2S release at 300 uM by WSP1 dye based spectrofluorometric method2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects.
AID1637831Cytotoxicity against human A549 cells assessed as reduction in cell viability at 50 to 500 uM by CellTiter-Glo luminescent assay2019MedChemComm, Jan-01, Volume: 10, Issue:1
Synthesis and preliminary evaluation of the anti-cancer activity on A549 lung cancer cells of a series of unsaturated disulfides.
AID1517868Induction of H2S generation in mouse BV2 cells at 100 uM after 45 mins by WSP-1 fluorescence dye based spectrofluorimetric analysis2019European journal of medicinal chemistry, Dec-15, Volume: 184Design and synthesis of H
AID1475787Drug metabolism in HSMC assessed as H2S release at 300 uM by WSP1/propidium iodide staining based fluorescence microscopic method2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects.
AID1622989Antiproliferative activity against human DLD1 cells2018European journal of medicinal chemistry, Oct-05, Volume: 158HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors.
AID717933Cell cycle arrest in MDCK cells assessed as accumulation at G2/M phase at 100 uM after 16 hrs by flow cytometric analysis (Rvb = 19.8%)2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Effect of allyl sulfides from garlic essential oil on intracellular ca2+ levels in renal tubular cells.
AID717929Induction of intracellular calcium level in MDCK cells at 50 uM by Fura-2 in presence of calcium relative to diallyl trisulfide2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Effect of allyl sulfides from garlic essential oil on intracellular ca2+ levels in renal tubular cells.
AID1475776Drug metabolism in pH 7.4 PBS buffer assessed as H2S release by measuring H2S Cmax at 1 mM after 30 mins in presence of 4 mM L-Cysteine by amperometric method2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects.
AID777384Induction of H2S release in PBS buffer 10x at pH 7.4 assessed as maximal concentration of H2S at steady state after 15 mins in presence of L-cysteine2013ACS medicinal chemistry letters, Oct-10, Volume: 4, Issue:10
Arylthioamides as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo.
AID644232Induction of apoptosis in human HCT116 cells assessed as PARP cleavage at 50 uM from 24 to 48 hrs by Western blotting2012Bioorganic & medicinal chemistry, Feb-15, Volume: 20, Issue:4
Coumarin polysulfides inhibit cell growth and induce apoptosis in HCT116 colon cancer cells.
AID1637833Cytotoxicity against human A549 cells assessed as reduction in cell viability at 500 uM after 48 hrs by CellTiter-Glo luminescent assay relative to control2019MedChemComm, Jan-01, Volume: 10, Issue:1
Synthesis and preliminary evaluation of the anti-cancer activity on A549 lung cancer cells of a series of unsaturated disulfides.
AID1637832Cytotoxicity against human A549 cells assessed as reduction in cell viability at 50 uM after 48 hrs by CellTiter-Glo luminescent assay relative to control2019MedChemComm, Jan-01, Volume: 10, Issue:1
Synthesis and preliminary evaluation of the anti-cancer activity on A549 lung cancer cells of a series of unsaturated disulfides.
AID1622987Antiproliferative activity against human Caco2 cells2018European journal of medicinal chemistry, Oct-05, Volume: 158HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors.
AID717934Cell cycle arrest in MDCK cells assessed as accumulation at subG1 phase at 100 uM after 16 hrs by flow cytometric analysis (Rvb = 0.5%)2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Effect of allyl sulfides from garlic essential oil on intracellular ca2+ levels in renal tubular cells.
AID777383Induction of H2S release in PBS buffer 10x at pH 7.4 assessed as time required to reach concentration for 50% of Cmax in presence of L-cysteine2013ACS medicinal chemistry letters, Oct-10, Volume: 4, Issue:10
Arylthioamides as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo.
AID1475791Antihypertensive activity in Wistar rat model of L-NAME-induced hypertension assessed as decrease in basal systolic blood pressure at 133 umol/kg, ip measured at 5 mins interval for 30 mins relative to control2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects.
AID1475774Drug metabolism in pH 7.4 PBS buffer assessed as H2S release by measuring H2S Cmax at 1 mM after 30 mins in absence of L-Cysteine by amperometric method2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects.
AID1475778Vasorelaxing effect in endothelium-denuded Wistar rat thoracic aorta ring assessed as reduction in KCl-induced contractile tone at 1 mM relative to KCl2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects.
AID1802931FAS Activity Assay from Article 10.3109/14756360903179377: \\Inhibitory effects of thioethers on fatty acid synthase and 3T3-L1 cells.\\2010Journal of enzyme inhibition and medicinal chemistry, Apr, Volume: 25, Issue:2
Inhibitory effects of thioethers on fatty acid synthase and 3T3-L1 cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (452)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (2.65)18.7374
1990's55 (12.17)18.2507
2000's163 (36.06)29.6817
2010's181 (40.04)24.3611
2020's41 (9.07)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.97 (24.57)
Research Supply Index6.20 (2.92)
Research Growth Index5.24 (4.65)
Search Engine Demand Index83.57 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials16 (3.38%)5.53%
Reviews17 (3.59%)6.00%
Case Studies7 (1.48%)4.05%
Observational1 (0.21%)0.25%
Other433 (91.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]